G20 World Brain Mapping Initiative/Summit in Australia started with important messages of Collaboration from Congressman Chaka Fattah, Congressman Earl Blumenauer and Member of the Canadian Parliament Kirsty Duncan and pioneering work by the top G20 scientists
Nov 13, 2014, 03:27 ET
BRISBANE, Australia, Nov. 13, 2014 /PRNewswire/ -- Earlier this year in Milan, Italy, the Society for Brain Mapping & Therapeutics (SBMT) announced its G20 World Brain Mapping and Therapeutics Initiative. Today, the Amen Clinics, Compumedics Inc, SBMT, and BMF hold the first annual summit on G20 World Brain Mapping and Therapeutics Initiative in Brisbane, Australia on Nov. 13th in Mercure Hotel. "We have spent more than 3 years to formulate this initiative, which we announced it earlier this year in Milan and held the 11th Annual World Congress in Sydney this year in order to finally bring the G20 World Brain Mapping summit" said Dr. Kuldip Sidhu, Professor of Stem Cell at UNSW, the Past President of SBMT and a current President of SBMT-Australia.
The summit will start with messages of cooperation from the U.S. Congressman Fattah, the U.S. Congressman Blumenauer (Chairman of the Congressional Neuroscience Caucus) and Member of the Canadian Parliament Kirsty Duncan. These leaders encourage all scientists to work together to curb the growing cost associated with diagnosis and treatment of neurological disorders through introducing game-changing diagnostics and therapeutics.
The summit program includes talks from top US, Australian, Italian, Turkish, and European Brain Mapping Initiative scientists covering topics such as advanced imaging in diagnosis of Alzheimer's disease, psychiatric disorders, brain cancers, neurodegenerative disorders, big data in brain mapping, strategies for global clinical trials, policies that could facilitate translation, integration and commercialization of devices and therapeutics such as nanoneurosurgery/nanoneuroscience, neurotrauma, and military medicine, as well as a roundtable discussion with the US and Canadian Policymakers.
"Specifically, the goals of the program are to: Build solid working collaboration between the USA, Australia and other G20 nations on translational, clinical neuroscience including all aspects of the Brain Mapping and Therapeutics; Build strategic industry-academia-government alliance for brain discovery, disease prevention, diagnosis, and treatment; Facilitate rapid integration, translation, and commercialization of innovations in the field of Brain Mapping & Therapeutics worldwide; Launch complementary Brain Mapping Initiatives across the G20 nations; Facilitate clinical trial and formulation of joint Institutional Review Board taskforce across G20" said, Dr. Babak Kateb, Chairman of the Board of the SBMT and Research Scientist, Department of Neurosurgery, Cedars-Sinai Medical Center. "I am very happy that Australia took the lead on this topic and already planning the 2016 G20 World Brain Mapping Summit in Turkey with our Turkish colleagues."
Bryan Aroz: [email protected]
About SBMT: WWW.WorldBrainMapping.org
SOURCE Society for Brain Mapping and Therapeutics
Share this article